Assoc. Prof at Moldova State University, Moldova

Tamara Potlog is an Associate Professor of Chemistry at Moldova State University. She has extensive experience in materials science, particularly in the field of organic/inorganic materials for optoelectronics and photovoltaics.

Profile

Orcid

scholar

🎓 Education

Tamara Potlog earned her Ph.D. on August 7, 1992. Her research expertise lies in the field of semiconductor physics and materials science.

👨‍🔬 Experience

Tamara Potlog has over 30 years of experience in academia and research. She is currently the Head of the Laboratory of Organic/Inorganic Materials for Optoelectronics and has supervised numerous master’s and Ph.D. theses. She has also managed several national and international projects, including the COST CA20116 and COST CA21148 projects.

🔍 Research Interest

Tamara Potlog’s research focuses on the design and fabrication of photosensitizers for photodynamic therapy and photovoltaics. Her team has developed novel materials and techniques for cancer treatment and solar energy applications.

Awards and Honors 🏆

Tamara Potlog has received numerous awards and honors for her research contributions, including 20 medals (gold, silver, and bronze) at international exhibitions of inventions and innovations.

📚 Publications

1. Effect of deposition temperature on structural, morphological and optical properties of ZnTe thin films. 📊
2. DC current-voltage and impedance spectroscopy characterization of nCdS/pZnTe HJ. 💡
3. Thermally Annealed in Vacuum Undoped and Al-Doped ZnO Thin Films for Multifunctional Applications. 🔥
4. Physical-Chemical Properties of Self-Assembled Structures in Solution of Zinc Phthalocyanine and Bis-3-pentyl-PTCDI Derivative. 🌟
5. Influence of RF sputtering power and thickness on structural and optical properties of NiO thin films. 💻
6. The Photophysical Properties of Ga-doped ZnO Thin Films Grown by Spray Pyrolysis Method. ☀️
7. Photophysical properties of linked zinc phthalocyanine to acryloyl chloride:N-vinylpyrrolidone copolymer. 🎯
8. Photophysics of tetracarboxy-zinc phthalocyanine photosensitizers. 🔬
9. Reduced Recombination Current Due to Sputtered CdO Nanolayer at CdS/CdTe Interface. 💡
10. Photosensitizers for photodynamic and photovoltaic therapy. 🌞

Conclusion

Dr. Tamara Potlog is a strong candidate for the Research for Best Researcher Award, given her extensive research experience, leadership roles, and project management expertise. Her research focus on photosensitizers for photodynamic therapy and photovoltaics demonstrates innovation and potential for practical applications. With some further emphasis on international collaboration, citation impact, and research commercialization, she could further enhance her research profile and impact. Overall, she is a deserving candidate for the Research for Best Researcher Award.

Assist. Prof. Dr Eun Young Kim | Chronic disease | Best Researcher Award

Posted on 12/05/202515/05/2025 by ScienceFather

Assist. Prof. Dr Eun Young Kim | Chronic disease | Best Researcher Award

Assistant professor, Soonchunhyang University, South Korea

The Associate Professor is a dedicated nursing professional with a strong academic background and extensive experience in patient care and education. With a Ph.D. degree from Korea University Graduate School of Nursing Science, she has established herself as a researcher and educator in the field of nursing. Currently, she serves as an Assistant Professor at Soonchunhyang University’s School of Nursing, where she imparts knowledge and skills to the next generation of nurses. Her research focuses on improving patient care, particularly for vulnerable populations such as the elderly and those with dementia. Through her scientific publications and presentations, she contributes to the advancement of nursing science and practice.

Profile

scholar

orcid

🎓 Education

– Ph.D. Degree: Korea University Graduate School of Nursing Science (2011) 🎓– *MSN Degree*: Korea University Graduate School of Nursing Science (2006) 📚– *Bachelor’s Degree*: Korea University College of Nursing Science (2006) 🛠️– *Registered Nurse License*: The Ministry of Health and Welfare (No 224617)

👨‍🔬 Experience

Registered Nurse: Hemodialysis Unit, Korea University Guro Hospital (2006.02 ~ 2012.08) 🏥 Instructor: Red Cross College of Nursing, Chung-Ang University, Seoul, Korea (2015.03 ~ 2022.09) 📖 Assistant Professor: School of Nursing, Soonchunhyang University, Cheonan, Korea (2022.09 ~ present)

Awards and Honors

– *National Research Foundation of Korea grant*: Funded by the Korea government (NRF-2021R1I1A1A01048956) 💸– *Poster presentation*: Spring Conference of Korean Academy of Fundamentals of Nursing (2012) 🎉– *Poster presentation*: The 20th IAGG WORLD CONGRESS OF GERONTOLOGY AND GERIATRICS (2013

🔍 Research Interest

– *Patient care*: Improving care for vulnerable populations, such as the elderly and those with dementia 👴– *Nursing science*: Advancing nursing practice through research and education 🔬– *Practical algorithm development*: Creating practical algorithms for managing dehydration/electrolyte imbalance in nursing home residents

📚 Publications

Son, Y.-J., Han, J., Kim, E.Y. (2025). Shared decision-making in choosing dialysis modalities for patients with chronic kidney disease: An evolutionary concept analysis. Nursing & Health Sciences, 27, e70099. https://doi.org/10.1111/nhs.70099

Kim, E.Y., Lee, Y.-N., Chang, S.O. (2025). How nursing home nurses who care for residents with dementia experience the moral distress: A phenomenography study. Nursing Open, 12, e70171. https://doi.org/10.1002/nop2.70171

Hong, S.J., Kim, E.Y. (2024). General hospital nurses’ experience and perception of person-centered care: A phenomenological study. Nursing & Health Sciences, 26(4), e70007. https://doi.org/10.1111/nhs.70007

Son, Y.-J., Baek, K.-H., Kim, E.Y. (2024). Longitudinal trajectories of self-reported cognitive function and associated factors among older cancer survivors. Western Journal of Nursing Research, 46(9), 674-684. https://doi.org/10.1177/01939459241273390

Son, Y.J., Kim, D.Y., Choi, Y.G., Kim, E.Y. (2023). Eight-year trajectories and predictors of cognitive function in community-dwelling Korean older adults with cardiovascular diseases. Journal of Nursing Scholarship, 56(1), 153-163. https://doi.org/10.1111/jnu.12930

Kim, E.Y., Hong, S.J. (2023). Real-life experiences of chemotherapy-induced peripheral neuropathy in patients with cancer: A qualitative meta-synthesis study. Seminars in Oncology Nursing, 39(5), 151499. https://doi.org/10.1016/j.soncn.2023.151499

Son, Y.-J., Kim, E.Y. (2023). The effectiveness and usability of a novel mobile phone-based self-care intervention for patients with heart failure: A mixed-methods pilot study. European Journal of Cardiovascular Nursing, 22(3), 254–263. https://doi.org/10.1093/eurjcn/zvac077

Kim, T.Y., Kim, E.Y., Chang, S.O. (2023). Exploring post-transplant life in kidney transplant recipients taking immunosuppressive medication: A phenomenological study. Collegian, 30(2), 278-285. https://doi.org/10.1016/j.colegn.2022.08.011

Lee, Y.N., Kim, E.Y. (2022). Experiences of nurses caring for hemodialysis patients: A qualitative meta-synthesis study. Korean Journal of Adult Nursing, 34(2), 168-177. https://doi.org/10.7475/kjan.2022.34.2.168

Kim, E.Y., Chang, S.O. (2022). Exploring nurse perceptions and experiences of resilience: A meta-synthesis study. BMC Nursing, 21, 26. https://doi.org/10.1186/s12912-021-00803-z

Chang, S.O., Kim, E.Y. (2022). The resilience of nursing staff in nursing homes: Concept development applying a hybrid model. BMC Nursing, 21, 129. https://doi.org/10.1186/s12912-022-00913-2

Chang, S.O., Kim, E.Y. (2022). Ways that nursing home nursing staff build resilience: A phenomenographic approach. BMC Geriatrics, 22, 861. https://doi.org/10.1186/s12877-022-03582-7

Kim, E.Y., Chang, S.O. (2022). Exploring carer resilience in the context of dementia: A meta-synthesis. BMC Geriatrics, 22, 806. https://doi.org/10.1186/s12877-022-03516-3

Shin, J.W., Kim, E.Y., Son, Y.J. (2022). Home-dwelling older adults’ experiences of living with both frailty and multimorbidity: A meta-ethnography. Geriatric Nursing, 47, 191-200. https://doi.org/10.1016/j.gerinurse.2022.07.015

Kim, E.Y., Chang, S.O. (2022). A meta-synthesis study of person-centered care experience from the perspective of nursing home residents. International Journal of Environmental Research and Public Health, 19(14), 8576. https://doi.org/10.3390/ijerph19148576

Kim, E.Y., Chang, S.O. (2022). Person-centered care experience of nursing home workers: A qualitative meta-synthesis study. Journal of Korean Gerontological Nursing, 24(1), 33-46. https://doi.org/10.17079/jkgn.2022.24.1.33

Kim, E.Y., Lee, Y.N. (2022). Coexisting with the life of patients with hemodialysis: Qualitative meta-synthesis study of life of caregivers of patients with hemodialysis. International Journal of Environmental Research and Public Health, 19(4), 2163. https://doi.org/10.3390/ijerph19042163

Kang, M., Kim, E.Y., Chang, S.O. (2022). Nurses’ management of older patients with post-anesthesia delirium: A Q methodology approach. Journal of Korean Gerontological Nursing, 24(4), 454-463. https://doi.org/10.17079/jkgn.2022.24.4.454

Kim, E.Y., Hong, S.J. (2021). Decision-making experience of older patients with cancer in choosing treatment: A qualitative meta-synthesis study. Journal of Korean Gerontological Nursing, 23(4), 418-430. https://doi.org/10.17079/jkgn.2021.23.4.418

Kim, E.Y., Chang, S.O. (2021). Qualitative meta-synthesis of nurses’ caring experience for people with dementia. Journal of Korean Academy of Fundamental Nursing, 28(3), 372-383. https://doi.org/10.7739/jkafn.2021.28.3.372

Conclusion

The researcher demonstrates potential for the Best Researcher Award, with a strong academic background, research experience, and teaching experience. By addressing areas for improvement, such as strengthening her publication record, engaging in international collaborations, and defining a clear research focus, she can further solidify her position as a leading researcher in her field.

Dr. Claudia Bardoni | Chemo-Immunotherapy | Best Research Award

Posted on 28/04/202528/04/2025 by ScienceFather

Dr. Claudia Bardoni | Chemo-Immunotherapy | Best Research Award

MD FACS, IEO, Italy

Claudia Bardoni is a thoracic surgeon with extensive experience in thoracic surgery and research. Currently, she works as an Associate Thoracic Surgeon at the European Institute of Oncology (IEO) and is a member of the Nova Talent Network. She has worked in various prestigious institutions, including Università degli Studi di Milano and Cleveland Clinic Abu Dhabi.

Profile

orcid

🎓 Education

Although specific educational details are not provided, her experience suggests a strong foundation in medicine and surgery. She has completed fellowships in thoracic surgery, robotics, and microsurgery.

👨‍🔬 Experience

– Thoracic Surgeon at IEO- Resident Doctor at Università degli Studi di Milano- Clinical Fellow at Cleveland Clinic Abu Dhabi- Surgical Fellow at Klinikum Ernst von Bergmann- Medical Doctor in Covid-19 department

🔍 Research Interest

– Thoracic surgery- Lung transplant- Regenerative medicine- Robotics and microsurgery

🏆Awards and Honors

No specific awards or honors are mentioned, but her membership in the Nova Talent Network, which gathers the top 3% of professionals worldwide, is notable.

📚 Publications

– Evaluation of Methodological Quality of Published Guidelines: Dr. Bardoni co-authored a study evaluating the methodological quality of published guidelines for the surgical treatment of pleural mesothelioma, published in the European Journal of Cancer Prevention in 2023.
– Surgical Management of Superior Sulcus Tumors: She was part of a team that published a 20-year experience of surgical management of superior sulcus tumors at an oncological high-volume referral center in Frontiers in Oncology in 2023.
– Surgical Resection of Pulmonary Metastases: Dr. Bardoni contributed to a multicentric study on surgical resection of pulmonary metastases from melanoma in oligometastatic patients, published in Cancers in 2023.
– Non-Small Cell Lung Cancer: She co-authored a 20-year single-center retrospective study on surgically treated pT2aN0M0 non-small cell lung cancer, published in the Journal of Clinical Medicine in 2023.
– Molecular Biomarkers in Lung Cancer: Dr. Bardoni was involved in a narrative review analyzing molecular biomarkers in resected early-stage non-small cell lung cancer, published in Cancers in 2022.

Some of her other research interests and publications focus on:
– Reducing Postoperative Costs: Dr. Bardoni explored ways to reduce postoperative costs in thoracic surgery, including the use of oral management procedures to prevent complications.
– Body Composition and Complications: She investigated the relationship between CT-derived body composition values and complications after pneumonectomy in lung cancer patients ⁴.

Conclusion

This individual has a strong profile, with prestigious affiliations and editorial roles. While they have a solid foundation in research and clinical practice, more emphasis on publishing research findings, securing funding, and international collaborations would strengthen their application for the Best Researcher Award. With some additional focus on showcasing research achievements, they could demonstrate their suitability for the award.

Dr. Mostafa Alizade-Harakiyan | Nanoparticles in radiotherapy | Best Researcher Award

Posted on 26/04/202528/04/2025 by ScienceFather

Dr. Mostafa Alizade-Harakiyan | Nanoparticles in radiotherapy | Best Researcher Award

Medical physicist, Tabriz University of Medical Science, Iran

This medical physicist has a strong background in solid-state physics and medical physics. With experience working in various hospitals and oncology centers, they have developed expertise in radiation physics and health physics. Currently, they work as a Health Physicist at Urmia Radiotherapy and Oncology Center.

Profile

scholar

🎓 Education

– BSc in Solid State Physics from Urmia University
– MSc in Medical Physics from Tabriz University of Medical Sciences

👨‍🔬 Experience

– Internship Physicist at Tabriz Madani Hospital
– Medical Physicist at Tabriz Shahid Madani Hospital
– Radiation Physicist at Urmia Radiotherapy and Oncology Center
– Health Physicist at Urmia Radiotherapy and Oncology Center

🔍 Research Interest

– Radiation physics
– Medical physics
– Health physics

🏆Awards and Honors

No specific awards or honors are mentioned.

📚 Publications

1. “The Preventive Effects of Boron-Based Gel on Radiation Dermatitis in Patients Being Treated for Breast Cancer” 💊
2. “Investigating the effectiveness of iron nanoparticles synthesized by green synthesis method in chemoradiotherapy of colon cancer” ⚗️
3. “Durvalumab and taxane family combination therapy enhances the antitumoral effects for NSCLC” 🔬
4. “Investigation of the impact of copper nanoparticles coated with ocimum bassilicum at chemoradiotherapy of colon carcinoma”

Conclusion

By recognizing and rewarding excellence in nanoparticles in radiotherapy, we aim to inspire and motivate others to advance the field and improve cancer treatment outcomes.

Michael Honaker | Healthcare | Best Researcher Award

Posted on 20/09/202420/09/2024 by ScienceFather

Dr. Michael Honaker | Healthcare | Best Researcher Award

Associate Professor at , East Carolina University, Brody School of Medicine, United States

Dr. Michael Honaker is an Associate Professor of Surgery at East Carolina University’s Brody School of Medicine. Specializing in colorectal surgery, Dr. Michael Honaker serves as Co-Director of Colorectal Surgery at ECU Health and oversees multiple clinical committees. With extensive experience in both academic and clinical roles, Dr. Michael Honaker is dedicated to advancing colorectal cancer care through innovative techniques and improving patient outcomes. A recipient of numerous accolades for excellence in surgery and research, Dr. Michael Honaker is also committed to mentoring medical students and residents. Dr. Michael Honaker actively participates in national surgical societies, contributing to significant clinical research and educational efforts.

Publication Profile

orcid

Education 🎓

Dr. Michael Honaker completed a Bachelor of Science in Biology, magna cum laude, at West Virginia University, followed by a Doctor of Medicine from the West Virginia University School of Medicine, graduating in the top quartile of their class. 🏥 Post-medical education, Dr. Michael Honaker completed a General Surgery residency at Carolinas Medical Center and subsequently a Fellowship in Colorectal Surgery at William Beaumont Hospital. Dr. Michael Honaker further refined their surgical skills and academic focus during residency and fellowship training, excelling in colorectal surgery.

Experience 💼

Dr. Michael Honaker has held various academic appointments, currently serving as an Associate Professor of Surgery at ECU’s Brody School of Medicine.
🚑 Previous roles include Assistant Professor of Surgery at Mercer University School of Medicine and Clinical Associate Professor at ECU, where they have also coordinated surgical clerkships for medical students. Clinically, Dr. Michael Honaker has served at ECU Health as Co-Director of Colorectal Surgery, and prior positions include leadership roles at Navicent Health in Georgia.

Awards & Honors 🏅

Dr. Michael Honaker has received multiple awards for clinical excellence, including 2nd Place in Best Poster at the William Davidson Medical Education Week in 2016 and an Honorable Mention at Minimally Invasive Week in 2017. Their research on rectal cancer earned them recognition at the Graduate Medical Education Research Week, 2023, for Best Poster. Notably, Dr. Michael Honaker was elected to the Diseases of the Colon and Rectum Reviewer’s Guild Editorial Board and featured in Digestive Disease Week’s Top Abstracts.

Research Focus 🔬

Dr. Michael Honaker’s research is centered on colorectal cancer, including clinical trials like JANUS, exploring innovative approaches to improve chemotherapy outcomes.
🚑 Key research areas include improving access to cancer care for rural patients, addressing transportation barriers, and enhancing organ preservation in elderly patients with rectal cancer. Their work also involves developing validated measures for patient risk in cancer care and contributing to precision medicine solutions, funded by Lilly USA.

Publication Top Notes

Perianal Alveolar Rhabdomyosarcoma – A Rare Case
Clinical Case Reports, September 2024
DOI: 10.1002/ccr3.9437
Contributors: Anas Taha, Amjad Maeky, Larissa Wentzler, Stephanie Taha‐Mehlitz, Robert Rosenberg, Michael D. Honaker.
Postoperative BMI Predictive Model in Bariatric Surgery
Surgery for Obesity and Related Diseases, July 2024
DOI: 10.1016/j.soard.2024.06.012
Contributors: Vincent Ochs, Anja Tobler, Julia Wolleb, Florentin Bieder, Baraa Saad, Bassey Enodien, Laura E. Fischer, Michael D. Honaker, Susanne Drews, Ilan Rosenblum, et al.
Colorectal Cancer Screening and Mortality Disparities
Journal of Surgical Research, June 2024
DOI: 10.1016/j.jss.2024.03.040
Contributors: Michael D. Honaker, Ashley E. Burch, Jan H. Wong, Warqaa M. Akram, William D. Irish.
Virtual Reality in Abdominal Surgery – A Scoping Review
International Journal of Medical Robotics and Computer Assisted Surgery, February 2024
DOI: 10.1002/rcs.2623
Contributors: Vincent Ochs, Baraa Saad, Stephanie Taha‐Mehlitz, Sebastian Staubli, Katerina Neumann, Laura Fischer, Michael D. Honaker, et al.
Rectal Cancer Presentation During COVID-19
PLOS ONE, September 2023
DOI: 10.1371/journal.pone.0291447
Contributors: Tia S. Sutton, Marianna De Camargo Cancela, Scarlett Hao, Mizuki Suzuki, Aimei Chua, Anna Lisa Ciarrocca, Michael D. Honaker.
Rural–Urban Disparities in Colon Cancer Care
Annals of Surgical Oncology, June 2023
DOI: 10.1245/s10434-023-13381-y
Contributors: Michael D. Honaker, William Irish, Alexander A. Parikh, Rebecca A. Snyder.
Emergency Surgery for Diverticulitis – Age and Procedure Outcomes
Journal of the American Medical Directors Association, April 2022
DOI: 10.1016/j.jamda.2022.02.001
Contributors: Seth Quinn, Warqaa Akram, Scarlett Hao, Michael D. Honaker.

Conclusion:

Overall, the candidate presents a well-rounded and distinguished profile, excelling in clinical practice, research, and education. Their leadership in colorectal surgery, research on cancer care, and numerous accolades position them as a highly qualified contender for the Best Researcher Award. With continued growth in securing high-impact grants and international collaborations, their contributions to medical research could expand even further, making them an exemplary researcher and clinician.

Denian Wang | Tumor microenvironment | Young Scientist Award

Posted on 16/09/202416/09/2024 by ScienceFather

Assoc Prof Dr Denian Wang | Tumor microenvironment | Young Scientist Award

Assoc Prof Dr Denian Wang , West China Hospital of Sichuan University , China

Denian Wang is an Associate Professor at the Precision Medicine Center, West China Hospital, Sichuan University. His research focuses on tumor biology and cancer diagnostics, with a significant emphasis on the tumor microenvironment and early detection of lung cancer. Wang has garnered extensive funding for his work, including from the National Natural Science Foundation of China and the Natural Science Foundation of Sichuan Province. His research has resulted in numerous high-impact publications, reflecting his expertise and contribution to the field. Wang is dedicated to advancing cancer research and improving clinical outcomes through innovative approaches. 🔬📚

Publication Profile

Scopus

Strengths for the Award

Innovative Research Focus: Dr. Denian Wang’s research on tumor microenvironment, tumor metabolism, and early diagnosis of lung cancer aligns with cutting-edge areas of cancer research. His work on the immune microenvironment and tumor metabolism is particularly noteworthy for advancing understanding in these critical areas.
High-Impact Publications: Dr. Wang has published extensively in high-impact journals such as Nature Communications and Breast Cancer Research. His research is well-regarded in the field, as evidenced by the impact factors of the journals and the citations of his work.
Significant Funding: Dr. Wang has secured substantial funding from prominent sources, including the National Natural Science Foundation of China and the Natural Science Foundation of Sichuan Province. This reflects strong support for his research and its perceived importance in the scientific community.
Diverse Research Contributions: His diverse publications cover a range of topics within cancer biology and related fields, indicating a broad expertise and a significant contribution to various aspects of the field.

Areas for Improvement

Broader Impact and Outreach: While Dr. Wang’s research is highly specialized, increasing efforts to translate findings into clinical practice or public health improvements could enhance the broader impact of his work.
Collaborative Networks: Expanding collaborations with international researchers and institutions could further enhance the visibility and impact of his research. This could also facilitate access to additional resources and expertise.
Integration of Emerging Technologies: Incorporating emerging technologies, such as advanced bioinformatics or AI-driven approaches, could potentially enhance the scope and impact of his research.

Education

Denian Wang completed his Postdoctoral training in Clinical Medicine at West China Hospital, Sichuan University (2019-2022). He earned his PhD in Cell Biology from the State Key Laboratory of Biotherapy, Sichuan University (2014-2019). His education has provided a robust foundation in clinical and research medicine, equipping him with the skills necessary for cutting-edge research in cancer biology. 🎓🧬

Experience

Denian Wang is currently an Associate Professor at the Precision Medicine Center, West China Hospital, Sichuan University (2022-present). Prior to this, he served as an Associate Professor and Assistant Professor in the Department of Respiratory and Critical Care Medicine at the same hospital (2019-2022). His roles involved advanced research, clinical practice, and mentoring within the fields of respiratory medicine and clinical research. 🏥👨‍⚕️

Research Focus

Denian Wang’s research interests include the tumor microenvironment, tumor metabolism, and immune interactions within cancer. He is particularly focused on early lung cancer diagnosis and using deep learning for malignancy risk estimation. His work aims to enhance understanding of cancer biology and improve diagnostic and therapeutic strategies. 🧪🔍

Publications Top Notes

Intermedin protects against sepsis by concurrently re-establishing the endothelial barrier and alleviating inflammatory responses – Nat Commun, 2018. 🌟
Sunitinib facilitates metastatic breast cancer spreading by inducing endothelial cell senescence – Breast Cancer Res, 2020. 🌟
Blockade of macrophage-associated programmed death 1 inhibits the pyroptosis signalling pathway in sepsis – Inflamm Res, 2021. 🌟
Tau aggravates stress-induced anxiety by inhibiting adult ventral hippocampal neurogenesis in mice – Cereb Cortex, 2023. 🌟
Endoplasmic Reticulum Peroxynitrite Fluctuations in Hypoxia-Induced Endothelial Injury and Sepsis with a Two-Photon Fluorescence Probe – Anal Chem, 2023. 🌟
LACTB suppresses migration and invasion of glioblastoma via downregulating RHOC/Cofilin signaling pathway – Biochem Biophys Res Commun, 2022. 🌟
Predictive value of circulating cell-free DNA in the survival of breast cancer patients: A systemic review and meta-analysis – Medicine (Baltimore), 2018. 🌟
Simultaneous Monitoring of HOCl and Viscosity with Drug-Induced Pyroptosis in Live Cells and Acute Lung Injury – Anal Chem, 2022. 🌟
Intermedin (adrenomedullin 2) promotes breast cancer metastasis via Src/c-Myc-mediated ribosome production and protein translation – Breast Cancer Res Treat, 2022. 🌟
4R Tau Modulates Cocaine-Associated Memory through Adult Dorsal Hippocampal Neurogenesis – J Neurosci, 2021. 🌟

Conclusion:

Dr. Denian Wang is a strong candidate for the Research for Young Scientist Award due to his innovative research, high-impact publications, and significant funding achievements. His work contributes significantly to the understanding of cancer biology and offers potential advancements in early diagnosis and treatment. Addressing areas for improvement, such as broader impact and enhanced collaboration, could further strengthen his position as a leading researcher in his field. Overall, his accomplishments and ongoing contributions make him a deserving candidate for this prestigious award.

Harry Fuentes | Head and Neck Oncology | Best Researcher Award

Posted on 21/08/202421/08/2024 by ScienceFather

Dr. Harry Fuentes | Head and Neck Oncology | Best Researcher Award

Dr. Mayo Clinic, United States

This detailed academic and professional record belongs to Dr. Harry Eduardo Fuentes Bayne, MD, MS. He is an Assistant Professor of Oncology and Assistant Professor of Medicine at the Mayo Clinic College of Medicine and Science, with current positions as a Consultant in the Division of Medical Oncology, Department of Oncology at Mayo Clinic, Rochester, Minnesota.

Professional Profiles:

google Scholar

Education:

Doctor of Medicine Universidad de Guayaquil, Guayaquil, Ecuador 05/02/2005 – 09/13/2011Residency, Internal Medicine John H. Stroger Jr, Hospital of Cook County, Chicago, Illinois 07/01/2014 – 06/30/2017Masters of Clinical Research Rush University, Chicago, Illinois 05/13/2015 – 05/13/2017Chief Resident John H. Stroger Jr, Hospital of Cook County, Chicago, Illinois 07/01/2017 – 06/30/2018Fellow, Hematology/Oncology Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine, Rochester, Minnesota 07/01/2018 – 06/30/2021Chief Fellow Mayo Clinic Division of Hematology/Oncology Fellowship, Rochester, Minnesota 06/01/2020 – 06/01/2021

Honors and Awards:

Mencion de HonorEscuela de Medicina de la Universidad de Guayaquil Annual Academic Achievement award received each year of Medical School (7 years)
06/01/2005 – 09/01/2011Premio Contenta Escuela de Medicina de la Universidad de Guayaquil Highest academic performance recognition given to a Medical Graduate.
09/01/2011 – PresentPremio Unico Ministry of Public Health of Ecuador Awarded by the National Institute of Hygiene and Tropical Medicine 11/15/2011 – Present

Strengths for the Award

Educational Background and Training: Dr. Fuentes-Bayne has a robust educational and training background, including:
- A Doctor of Medicine from Universidad de Guayaquil.
- Residency in Internal Medicine at John H. Stroger Jr. Hospital of Cook County.
- A Master’s in Clinical Research from Rush University.
- Fellowship and Chief Fellowship in Hematology/Oncology at Mayo Clinic.
Honors and Awards: He has received multiple prestigious awards, including:
- Mencion de Honor from Escuela de Medicina de la Universidad de Guayaquil.
- Premio Contenta, recognizing highest academic performance.
- Premio Unico from the Ministry of Public Health of Ecuador.
Leadership and Expertise: His role as Chief Resident and Chief Fellow indicates strong leadership skills and advanced expertise in his field. His extensive training in Hematology/Oncology is particularly noteworthy.
Institutional Affiliation: Being affiliated with Mayo Clinic, a leading institution, adds credibility and indicates a high level of expertise and access to cutting-edge research and clinical resources.

Areas for Improvement

Publication Record: While the provided highlights his educational and award history, details on his publication record, research contributions, or specific projects in hematology/oncology would be beneficial. A strong publication record in high-impact journals is often a key criterion for research awards.
Research Impact: Information on the impact of his research, such as citation counts, novel contributions to the field, or involvement in significant research projects, would provide a clearer picture of his influence in the field.
Continued Professional Development: Details on ongoing research activities, involvement in conferences, or contributions to professional societies would enhance the understanding of his current research engagement and professional growth.

✍️Publications Top Note :

Comparative effectiveness of anticoagulants in patients with cancer-associated thrombosis

Authors: IB Riaz, H Fuentes, Y Deng, SAA Naqvi, X Yao, LR Sangaralingham, …

Journal: JAMA Network Open

Volume/Issue: 6 (7), e2325283-e2325283

Citations: 11

Year: 2023

Risk assessment as a guide for the prevention of cancer-associated thromboembolism

Authors: A Al-Ogaili, HE Fuentes, AJ Tafur, J Caprini

Journal: International Angiology

Volume/Issue: Not specified

Citations: 9

Year: 2018

Primary liver diffuse large B-cell lymphoma following complete response for hepatitis C infection after direct antiviral therapy

Authors: XA Andrade, LH Paz, DM Oramas, HE Fuentes, P Kovarik, S Mishra, …

Journal: Acta Haematologica

Volume/Issue: 139 (2), 77-80

Citations: 9

Year: 2018

Predictors of active cancer thromboembolic outcomes: mortality associated with calf deep vein thrombosis

Authors: JPS Adum, LD Quintero, HE Fuentes, BB Lind, JA Caprini, AJ Tafur

Journal: International Angiology

Volume/Issue: Not specified

Citations: 9

Year: 2017

Conclusion

Dr. Harry Fuentes-Bayne demonstrates significant strengths in his educational background, leadership roles, and receipt of prestigious awards, which collectively position him as a strong candidate for a Research Award. To strengthen his candidacy further, providing detailed information about his research contributions, publication record, and ongoing projects would be advantageous. His strong academic and clinical background, coupled with notable awards, makes him a compelling candidate for recognition in the research community.

Prof Dr. Catherine Alix-Panabieres | Biopsie Liquide | Excellence in Research

Posted on 29/05/202429/05/2024 by ScienceFather

Prof Dr. Catherine Alix-Panabieres | Biopsie Liquide | Excellence in Research

Prof Dr. Catherine Alix-Panabieres , CHU de Montpellier, France

Prof Dr. Catherine Alix-Panabieres is academic and researcher in the field of renewable energy, holds a PhD in Bio systems Engineering from Kangwon National University, South Korea. His academic journey has been marked by a profound dedication to advancing solar energy technologies, specifically in solar thermal harvesting and its integration into agricultural and architectural applications.

Professional Profiles:

Orcid

Google scholar

Position 🏥

Discipline: OncologyFunction: Professeur des Universités – Praticien Hospitalier (PU-PH); Full ProfessorLaboratory: Director of the Laboratory of Detection of Rare Circulating Human – LCCRH, Department of Pathology and Onco-Biology, University Medical Center of Montpellier – IURC, 641, avenue du Doyen Gaston Giraud, 34093 Montpellier Cedex 5 & CREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD, Montpellier, France.Phone: +33 4 11 75 99 31 / +33 6 88 80 06 74 (Mobile)Fax: +33 4 67 33 52 81

Academic Qualifications 🎓

2023: University Diploma in Medical Education and Communication2012: Habilitation (University of Montpellier, France)1995/98: PhD obtained on 25th November 1998 (University Louis Pasteur Strasbourg, France)1994/95: Master 2 in Molecular and Cellular Biology (Prof Jules Hoffmann, Nobel prize – ULP Strasbourg, France)

Professional Career Development 🚀

2023-24: Full Professor at the University of Montpellier2010-23: Maître de Conférences – Praticien Hospitalier (UMC and University of Montpellier)1999-2009: Post-doctorant (2 years) then researcher (9 years) at the UMC of Montpellier2022-2026: Visiting Professor at the University of Hamburg, Germany2021-24: Top 25 best researchers at the CHU of Montpellier2020-24: Work-package leader of the European Liquid Biopsy Society (ELBS)2020-23: Consultant for Menarini as an expert in the liquid biopsy field

Key Achievements and Honors 🏆

2016: Active Member of the European Society of Medical Oncology (ESMO)2013-18: Active Member of Pilot committee of the Pole of Cancer Research ‘SIRIC’ – Colon cancer axis2013: Creation and President of the Association « BIODETECT »2006 & 2002: Patents for innovative cancer detection technologies2021: International Liquid Biopsy Society (ISLB) Award for Lifetime Achievement2022: Prestigious Alexandr Savchuk Award

Key Publications 📚

h-index: 58i10-index: 113Citations: 16,738Notable Publications:”Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer.” Br J Cancer. 2023″Overall Survival With Circulating Tumor Cell Count-Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial.” J Clin Oncol. 2023″Liquid Biopsy: From Discovery to Clinical Application.” Cancer Discovery 2021

Teaching Activity 🎓

Experience: Over 15 years of teaching in Oncology at the Faculties of Medicine and Sciences, University of MontpellierInternational Teaching: Bari (Italy), Beirut (Lebanon), Zürich (Switzerland), Aarhus (Denmark)Supervision: 20 theses, 9 Master 2, and 10 Master 1 students since 2016Publications: 14 education book chapters and reviews

Short Biography ✨

Professor Catherine Alix-Panabières earned her PhD in 1998 from the University Louis Pasteur in Strasbourg, France. She has made significant strides in the field of oncology, particularly in the optimization of techniques for detecting and characterizing viable circulating tumor cells (CTCs). Notably, she co-coined the term ‘Liquid Biopsy’ and has received numerous awards for her contributions to cancer research. As the director of the Laboratory of Rare Human Circulating Cells (LCCRH), she continues to advance the field with innovative research and international collaborations.Her notable achievements include patents for cancer detection technologies, recognition from prestigious institutions such as the French Academy of Medicine, and significant contributions to the global understanding and application of liquid biopsy techniques in cancer research. Her work has been widely published and cited, reflecting her impact on the field of oncology.

📖 Publications Top Note :

Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells

Demographic Analysis of Cancer Research Priorities and Treatment Correlations

Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis